rs543886209
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The ENST00000367057.8(CR2):āc.389T>Cā(p.Val130Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,611,190 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000367057.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CR2 | NM_001006658.3 | c.389T>C | p.Val130Ala | missense_variant | 2/20 | ENST00000367057.8 | NP_001006659.1 | |
CR2 | NM_001877.5 | c.389T>C | p.Val130Ala | missense_variant | 2/19 | NP_001868.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CR2 | ENST00000367057.8 | c.389T>C | p.Val130Ala | missense_variant | 2/20 | 1 | NM_001006658.3 | ENSP00000356024 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152150Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000261 AC: 65AN: 249096Hom.: 1 AF XY: 0.000386 AC XY: 52AN XY: 134626
GnomAD4 exome AF: 0.000122 AC: 178AN: 1458922Hom.: 3 Cov.: 32 AF XY: 0.000183 AC XY: 133AN XY: 725612
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152268Hom.: 1 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74458
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | The c.389T>C (p.V130A) alteration is located in exon 2 (coding exon 2) of the CR2 gene. This alteration results from a T to C substitution at nucleotide position 389, causing the valine (V) at amino acid position 130 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Immunodeficiency, common variable, 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 13, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at